EB-1020 (Centanafadine) high dose Clinical Trials
2 recruitingDrug
Phase 32Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.315 enrolled1 locationNCT07086313
Recruiting
Phase 3
A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.180 enrolled1 locationNCT07087327